List view / Grid view

GAVI Alliance



Gavi funds Merck’s development of Ebola vaccine

20 January 2016 | By Victoria White

Gavi has provided US$ 5 million towards the development of Merck’s rVSV∆G-ZEBOV-GP live attenuated Ebola Zaire vaccine, on the understanding that it will be submitted for licensure by the end of 2017...